Trial
NCT03804424
64Cu-LLP2A for Imaging Multiple Myeloma
Early Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Washington University School of Medicine
Collaborators
—
Condition
Multiple Myeloma
Intervention
64Cu-LLP2A
Why stopped
Drug formulation changed, opening new trial
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-11-12